Back to School: How biopharma can reboot drug development. Access exclusive analysis here

Yondelis ecteinascidin: Phase I

PharmaMar said that in an ongoing Italian Phase I study of Yondelis plus cisplatin

Read the full 144 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE